228 related articles for article (PubMed ID: 27306689)
1. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
Zwicker JI; Karp Leaf R; Carrier M
J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
[TBL] [Abstract][Full Text] [Related]
2. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
[TBL] [Abstract][Full Text] [Related]
3. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review.
Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R
J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517
[TBL] [Abstract][Full Text] [Related]
4. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.
Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI
Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors.
Mantia C; Zwicker JI
Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488
[TBL] [Abstract][Full Text] [Related]
6. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
[TBL] [Abstract][Full Text] [Related]
7. Intracranial hemorrhage in cancer patients treated with anticoagulation.
Weinstock MJ; Uhlmann EJ; Zwicker JI
Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
[TBL] [Abstract][Full Text] [Related]
9. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jo J; Donahue J; Sarai G; Petroni G; Schiff D
Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
Lin RJ; Green DL; Shah GL
Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
[TBL] [Abstract][Full Text] [Related]
11. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis.
Yang J; He Z; Li M; Hong T; Ouyang T
J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715
[TBL] [Abstract][Full Text] [Related]
12. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Rojas-Hernandez CM; Oo TH; García-Perdomo HA
J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
[TBL] [Abstract][Full Text] [Related]
13. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA
Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956
[TBL] [Abstract][Full Text] [Related]
14. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients.
Norden AD; Bartolomeo J; Tanaka S; Drappatz J; Ciampa AS; Doherty LM; Lafrankie DC; Ruland S; Quant EC; Beroukhim R; Wen PY
J Neurooncol; 2012 Jan; 106(1):121-5. PubMed ID: 21706358
[TBL] [Abstract][Full Text] [Related]
15. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage.
Nguyen T; Sharma M; Crooks P; Patel PV; Bonow RH; Creutzfeldt CJ; Wahlster S
Br J Neurosurg; 2022 Apr; 36(2):251-257. PubMed ID: 35343356
[TBL] [Abstract][Full Text] [Related]
16. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
Diaz M; Jo J
Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
[TBL] [Abstract][Full Text] [Related]
17. The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis.
Huo H; Shen S; Yang Y; Zhang H; Wu S; Bi T; Li Y
J Thromb Thrombolysis; 2023 Aug; 56(2):333-341. PubMed ID: 37341895
[TBL] [Abstract][Full Text] [Related]
18. Challenges in anticoagulation for patients with brain tumors.
Iyengar V; Patell R; Zwicker J
Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073
[TBL] [Abstract][Full Text] [Related]
19. Management of venous thromboembolism in patients with glioma.
Al Megren M; De Wit C; Al Qahtani M; Le Gal G; Carrier M
Thromb Res; 2017 Aug; 156():105-108. PubMed ID: 28624717
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review.
Hunter BD; Minichiello T; Bent S
J Thromb Thrombolysis; 2017 Oct; 44(3):392-398. PubMed ID: 28836150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
